| 摘要 |
The present invention provides a novel means of immunological therapy for cancer. More particularly, it provides a therapeutic agent for cancer which is administered by using inducing ability for IL-12 production and NKT cell activating ability as indexes or a therapeutic agent for cancer or a supplementary food preparation for oral administration containing a substance having an activating ability of NKT cells which is a supplementary food preparation by oral administration given with an expectation of anticancer effect. The present invention further provides a mixed composition containing at least two of a processed product of mycelia of Schizophyllum commune or a saccharide derived from cultured filtrate of mycelia of Schizophyllum commune and processed product of mycelia of Cortinellus shiitake and a processed product of Fomos glaucotus as a compounded substance at least maintaining an inducing ability of IL-12 production and an activating ability of NKT cells. The present invention furthermore provides a novel preparation of IL-12 production inducer and a novel NKT cell activator. |
